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Abstract
Drosophila has emerged as an excellent model system in which to study cellular and genetic aspects of hematopoiesis.
Under normal developmental conditions and in wild-type genetic backgrounds, Drosophila possesses two types of blood
cells, crystal cells and plasmatocytes. Upon infestation by a parasitic wasp or in certain altered genetic backgrounds, a third
hemocyte class called the lamellocyte becomes apparent. Herein we describe the characterization of a novel transcriptional
regulatory module, a lamellocyte-active enhancer of the misshapen gene. This transcriptional control sequence appears to
be inactive in all cell types of the wild-type larva, including crystal cells and plasmatocytes. However, in lamellocytes
induced by wasp infestation or by particular genetic conditions, the enhancer is activated and it directs reporter GFP or
DsRed expression exclusively in lamellocytes. The lamellocyte control region was delimited to a 140-bp intronic sequence
that contains an essential DNA recognition element for the AP-1 transcription factor. Additionally, mutation of the kayak
gene encoding the dFos subunit of AP-1 led to a strong suppression of lamellocyte production in tumorous larvae. As
misshapen encodes a protein kinase within the Jun N-terminal kinase signaling pathway that functions to form an active AP-
1 complex, the lamellocyte-active enhancer likely serves as a transcriptional target within a genetic auto-regulatory circuit
that promotes the production of lamellocytes in immune-challenged or genetically- compromised animals.
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Introduction
Blood cell production, also termed hematopoiesis, is a highly
conserved developmental process. Though separated by millions
of years of evolution, striking similarities exist between hemato-
poiesis in Drosophila and humans [1,2]. Such similarities include
multiple sites and times of blood cell production, the generation of
functionally distinct cell types from common hematopoietic
precursors, and the utilization of conserved signaling pathways
and transcriptional regulators for pro-hemocyte determination and
specific lineage differentiation. Furthermore, hemocyte popula-
tions are derived from progenitor hemangioblasts that give rise to
multiple cell fates within the mesoderm of both developmental
systems [3]. Thus due to this evolutionary conservation and the
rapid and sensitive approaches available, Drosophila has emerged as
a leading model system to discover and analyze genes controlling
hematopoiesis. Blood cell production in Drosophila occurs in two
spatiotemporal waves. Using blastoderm stage embryos, Holz and
co-workers [4] carried out single-cell transplantation experiments
and demonstrated pro-hemocytes arise from two different
embryonic anlagen. These are the cephalic mesoderm that gives
rise to embryonic hemocytes, and a thoracic mesodermal region
that will form the lymph glands, the organ for hematopoiesis
during larval development [5]. Drosophila hemocytes possess
characteristics similar to those blood cells found in vertebrate
myeloid lineages [6]. Embryo-derived types include crystal cells
and plasmatocytes [1,2]. Crystal cells constitute the minor class of
hemocytes and carry crystals of Prophenoxidase A1, a pro-enzyme
that is processed to form an active enzyme required for catalyzing
melanin synthesis during wound healing and encapsulation
reactions. Prophenoloxidase A1 is encoded by Black cells (Bc), a
gene expressed primarily in crystal cells [7]. In contrast,
plasmatocytes constitute the major class of hemocytes and their
chief function is in phagocytosis, engulfing apoptotic corpses
formed as a result of embryonic tissue development. Plasmatocytes
also secrete and remodel extracellular matrix important for animal
development and rid the animal of certain small invading
pathogens. Eater is a transmembrane protein that is expressed
solely in post-embryonic plasmatocytes where it mediates
phagocytosis of bacterial pathogens [8].
Embryo-derived blood cells persist into larval stages, where they
undergo multiple rounds of mitosis. By the end of the third larval
instar, about 6–8,000 hemocytes are observed in the circulating
hemolymph [9]. Crystal cells and plasmatocytes are also produced
PLoS ONE | www.plosone.org 1 July 2009 | Volume 4 | Issue 7 | e6429in the lymph gland during second and third larval instars, but these
hemocytes remain sequestered in the hematopoietic organs and not
contributed to circulation until metamorphosis. At that time, they
are released into the hemolymph, to assist in the histolysis of larval
tissues. Hematopoietic organs have not been identified in adult
Drosophila. Blood cells found in adult flies represent a mixed
population of hemocytes with embryonic or larval origins.
Lamellocytes constitute a third class of hemocytes, that when
induced, appear in the lymph glands and hemolymph during
larval development. These blood cells are large and flat with
adhesive properties, and they function to encapsulate and
neutralize objects that are too large to be phagocytized by
plasmatocytes. Lamellocyte induction can occur due to an
immune response to wasp parasitization [10,11]. It was recently
shown that lamellocytes that encapsulate wasp eggs are derived
mainly from a subepidermal population of sessile hemocytes
initially found in posterior segments of the larva [12]. Lamellocytes
can also be induced through genetic perturbation of specific signal
transduction pathways that can result in melanotic tumor
phenotypes [11]. Such genetic backgrounds include mutation or
forced expression of genes functioning in the JAK/STAT, Jun N-
terminal kinase (JNK), Toll, and Wingless (Wg) pathways [13].
Additionally, loss-of-function of the u-shaped (ush) gene, which
encodes a Friend of GATA class protein, culminates in a robust
production of lamellocytes [9].
The precise mechanisms of how these different signaling
pathways or transcriptional regulators function and/or interact
in lamellocyte induction and differentiation remain to be
elucidated. Nonetheless, some progress has been made in
investigating the role of the JAK/STAT pathway in regulating
lamellocyte production. The gain-of-function allele hop
Tum-l
encodes a constitutively active form of the Hopscotch (Hop) Janus
kinase (JAK) and larvae carrying this mutation exhibit a melanotic
tumor phenotype including extensive lamellocyte differentiation
[14]. Consistently, loss of function of Hop almost completely
suppressed the differentiation of larval lymph gland lamellocytes
Figure 1. Identification and initial characterization of a msn lamellocyte transcriptional enhancer. A. Genomic organization of the msn
gene and location of the 3.0-kb MSNF9 intron-3 DNA that possesses lamellocyte enhancer activity. B. Lack of MSNF9-GFP expression in a wild-type
third-instar larva. C. The MSNF9-GFP transgene is active in a hop
Tum-l third-instar larva. The open arrowhead points to MSNF9-GFP-positive lamellocytes
that have contributed to the formation of a melanotic tumor in this animal. D. MSNF9-GFP activity is not detected in circulating hemocytes present in
hemolymph obtained from a wild-type third-instar larva. E. MSNF9-GFP-positive lamellocytes present in hemolymph obtained from a hop
Tum-l third-
instar larva. F. Lack of co-expression of eater-GFP (plasmatocyte marker, arrowhead) and MSNF9-DsRed (lamellocyte marker, open arrowhead) in
circulating blood cells obtained from a hop
Tum-l third-instar larva. G. Lack of co-expression of lzGal4.UAS-GFP (crystal cell marker, arrowhead) and
MSNF9-DsRed (lamellocyte marker, open arrowhead) in circulating blood cells obtained from a hop
Tum-l third-instar larva.
doi:10.1371/journal.pone.0006429.g001
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wasp parasitization [15]. More recent studies demonstrated that
JAK over-activation results in a global disruption of heterochro-
matic gene silencing, with a de-repression of genes not normally
serving as targets of STAT regulation leading to enhanced
tumorigenesis [16]. Forced expression of the Ush transcriptional
co-regulator in hop
Tum-l larvae results in a 90% reduction of the
population of circulating lamellocytes, indicating Ush plays a
central role in the suppression of lamellocyte differentiation [9].
Two known markers for the lamellocyte lineage are an antigen
recognized by the L1 monoclonal antibody [17] and the enhancer
trap allele misshapen
03349 (msn
03349) [18]. Msn is a MAPK kinase
kinase kinase (MAPKKKK) within the JNK signaling cascade, a
pathway known to function in lamellocyte production [13] and in
Figure 2. Temporal activation of the msn lamellocyte transcriptional enhancer. A. Inactivity of the MSNF9-GFP transgene in lymph glands
dissected from a Basc/Y control larva at 72 hr of development. B. Inactivity of the MSNF9-GFP transgene in circulating hemocytes present in
hemolymph obtained from a Basc/Y control larva at 72 hr of development. C. MSNF9-GFP-positive hemocytes observed in lymph glands dissected
from a hop
Tum-l/Y mutant larva at 72 hr of development. D. MSNF9-GFP-positive lamellocytes present in the hemolymph obtained from a hop
Tum-l/Y
mutant larva at 72 hr of development. E. MSNF9-GFP-positive hemocytes observed in lymph glands dissected from a hop
Tum-l/Y mutant larva at 56 hr
of development. F. MSNF9-GFP-positive lamellocytes present in the hemolymph obtained from a hop
Tum-l/Y mutant larva at 42 hr of development.
doi:10.1371/journal.pone.0006429.g002
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and tissue morphogenesis [19]. Based on the ability of sequences
near or within the msn locus to direct PlacZ transgene expression in
lamellocytes, we initiated an analysis of this gene in search of its
lamellocyte-active transcriptional enhancer. In this report, we
characterize an intronic regulatory module that functions solely in
lamellocytes, being regulated by the AP-1 transcription factor.
These studies provide further molecular and genetic evidence on
the importance of the msn gene and JNK pathway signaling in
lamellocyte formation. They have also yielded highly-sensitive msn-
GFP and msn-DsRed transgenes that can be used to monitor the
induction and function of lamellocytes in immune-challenged or
genetically-altered Drosophila.
Results
A lamellocyte-active enhancer present within intron-3 of
the msn gene
msn
03349 is a PlacZ enhancer trap allele of msn that results in b-
galactosidase expression in lamellocytes induced in larvae due to
wasp parasitization [11,15,18]. Based on this finding, we initiated a
series of experiments to localize and characterize a transcriptional
Figure 3. MSNF9-GFP expression in circulating hemocytes obtained from third-instar larvae of different genetic backgrounds that
induce lamellocyte production. A. w
1118; He-Gal4 control. B. He-Gal4.UAS-dTCF
DN. C. He-Gal4.UAS-dRAC1. D. He-Gal4.UAS-hep
CA. E. Cg-
Gal4.UAS-col. F. Cg-Gal4.Ush
DN. Hemolymph samples were also stained for DNA (DAPI) and filamentous actin (phalloidin).
doi:10.1371/journal.pone.0006429.g003
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Enhancer analyses were initiated wherein ,22 kb of msn upstream
or intronic DNAs were cloned into P-element vectors containing
GFP or DsRed reporter genes and transgenic strains were
established that harbor the nine DNA-marker transgenes. Wild-
type larvae possessing the transgene insertions were monitored for
GFP or DsRed expression in blood cells present within the lymph
glands or hemolymph. To determine if msn DNAs possessed
enhancer activity in lamellocytes, expression of the various
transgenes was assayed after being crossed into the hop
Tum-l genetic
background. MSNF9 (Fig. 1A) is a 3.0-kb region of msn intron-3
possessing the desired characteristic of being active in lamellocytes
induced in hop
Tum-l animals (Fig. 1C and E), while being inactive in
other hematopoietic cell types within wild-type larva (Fig. 1B and
D). Comparing the cellular activity of MSNF9-DsRed with the eater-
GFPplasmatocyte(Fig.1F)orlzGal4.UAS-GFPcrystalcell(Fig.1G)
markers demonstrated the transcriptional enhancer within MSNF9
functioned solely in lamellocytes and not in the other two blood cell
types.
To determine when the MSNF9 lamellocyte enhancer initiated
transcriptional function, we conducted tightly-timed egg lays and
aging of control and hop
Tum-l animals that harbored the MSNF9-
GFP transgene. Lymph glands dissected from Basc/Y;MSNF9-
GFP/+ control larvae at 72 hr of development failed to exhibit any
lamellocyte differentiation or GFP expression (Fig. 2A). In
contrast, lymph glands obtained from hop
Tum-l/Y; MSNF9-GFP/+
test larvae at 72 hr of development showed lymph gland
hyperplasia, extensive lamellocyte differentiation, and robust
GFP expression (Fig. 2C). The analysis of multiple larvae indicated
that hop
Tum-l-induced lamellocytes reproducibly appeared in the
lymph glands around 54–56 hr of development at 25uC (Fig. 2E).
As expected, the analysis of hemolymph samples taken from
control larvae aged to 72 hr showed an absence of lamellocytes
and GFP-positive cells (Fig. 2B). In contrast, a large population of
GFP-positive lamellocytes was observed in hemolymph obtained
from hop
Tum-l larvae at 72 hr of development (Fig. 2D). Moving
back from this time point, MSNF9-GFP-positive hemocytes
reproducibly appeared in these mutant larvae before 56 hr of
development at 25uC, with rare positive hemocytes being detected
in the hemolymph of hop
Tum-l animals as early as 42 hr of
development (Fig. 2F). It is likely these early-appearing MSNF9-
GFP-positive hemocytes serve as precursors of the later appearing
lamellocyte population. Thus the msn transcriptional enhancer is
functional in blood cells within the hemolymph before becoming
active in cells of the lymph glands.
Lamellocyte production can be induced in a variety of genetic
backgrounds, including in larvae with forced hemocyte expression
of a dominant-negative version of dTCF (dTCF
DN) [13], a
transcriptional effector of the Wg pathway, and forced expression
of dRAC1 or a constitutively-active version of Hemipterous
(hep
CA) [13], two members of the JNK signaling pathway.
Likewise, forced hemocyte expression of transcriptional regulators
such as Collier (Col) [20] or a dominant-negative version of Ush
(Ush
DN) [9] culminate in precocious lamellocyte production. An
analysis of MSNF9-GFP expression in larvae of these five different
genotypes demonstrated the msn enhancer is active in lamellocytes
induced due to all of these genetic conditions (Fig. 3B–F). These
findings demonstrated the usefulness of the MSNF9-GFP transgene
for the detection of cells entering this specific hemocyte lineage.
The msn lamellocyte enhancer functions in larvae
mounting an immune response to wasp parasitization
In response to parasitoid wasp infestation, larvae rapidly
generate lamellocytes that function to encapsulate and neutralize
a deposited egg [10,11]. To determine if the MSNF9 enhancer
was active in lamellocytes induced under these more natural
conditions, wasps were incubated with larvae carrying the MSNF9-
GFP transgene. We initially monitored the induction of GFP
activity in lymph glands dissected from larvae incubated without
or with the parasite. While the MSNF9-GFP transgene was not
activated in the hematopoietic organs of control larvae (Fig. 4A),
the lamellocyte marker was induced in lymph glands obtained
from wasp-infested animals (Fig. 4B). Wasp parasitization likewise
resulted in the production of MSNF9-GFP-positive lamellocytes
within the hemolymph (Fig. 4C) and the generation of copious
numbers of lamellocytes that encapsulated a deposited egg
(Fig. 4D). These findings demonstrated the msn transcriptional
control sequence was functional in lamellocytes induced by a
natural immune-challenge as well as specific alterations of genetic
background.
Detailed molecular analysis of the msn lamellocyte
regulatory module
Having demonstrated the 3.0-kb MSNF9 interval of msn intron-
3 harbored a lamellocyte-active enhancer, we sought to more
precisely locate the transcriptional control sequence while also
investigating its means of regulation. As a start, three truncated
versions of MSNF9 were generated: MSNF9b, MSNF9e, and
MSNF9g (Fig. 5A). The first two represent 59-truncations of
MSNF9 and they both maintained enhancer activity in lamello-
cytes. In contrast, MSNF9g deletes both 59- and 39-sequences from
MSNF9, alterations that led to a loss of lamellocyte enhancer
function. Taken together, these initial delimitation analyses
Figure 4. MSNF9-GFP expression in larvae post L. boulardi
infestation. A. Lack of MSNF9-GFP activity in lymph glands dissected
from a control, non-wasp infested larva. B. MSNF9-GFP expression in
lymph glands dissected from a wasp infested larva. C. MSNF9-GFP-
positive lamellocyte present in the hemolymph of a wasp infested larva.
D. Detection of numerous MSNF9-GFP-positive lamellocytes encapsu-
lating a wasp egg (asterisk).
doi:10.1371/journal.pone.0006429.g004
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PLoS ONE | www.plosone.org 5 July 2009 | Volume 4 | Issue 7 | e6429Figure 5. Fine mapping of the location of the msn lamellocyte enhancer and its essential DNA sequence elements. A. Schematic of the
various truncated and sequence mutated msn intron-3 DNAs tested for enhancer function in lamellocytes of hop
Tum-l larvae as compared to
hemocytes of control larvae. B. Sequence of the 590-bp MSNF9e DNA with putative binding elements for the STAT, Srp, and AP-1 transcription factors
highlighted.
doi:10.1371/journal.pone.0006429.g005
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the 590-bp MSNF9e DNA.
The next set of lamellocyte enhancer test constructs involved the
generation and analysis of ten truncated versions of MSNF9e, with
the positions of the PCR primers carefully chosen based on the
locations of potential binding sites for the STAT, Srp, or AP-1
transcription factors (Fig. 5A). The MSNF9mo DNA was the
smallest region that maintained lamellocyte enhancer function in
these analyses. Thus we were able to delimit the regulatory module
to a 140-bp region of msn intron-3, a sequence that lacked putative
STAT and Srp binding elements but possessed an evolutionarily
conserved AP-1 binding element. To determine if this putative AP-
1 recognition element was essential for lamellocyte activity of the
enhancer, we mutated this sequence within the context of the 590-
bp MSNF9e DNA to generate the altered MSNF9e-mAP-1
construct. The precise mutation of this putative AP-1 binding site
fully abrogated lamellocyte enhancer function, strongly implicat-
ing the AP-1 transcription factor complex as a positive regulator of
this minimally-defined msn lamellocyte regulatory module.
Based on this mutagenesis and enhancer test result, electro-
mobility shift assays were undertaken to test the ability of the
combination of dFos (encoded by kayak, kay) and dJun (encoded by
Jun-related antigen, Jra) DNA binding domain proteins to interact
with a double-stranded oligonucleotide containing the AP-1
recognition element. We were unable to demonstrate a strong
interaction of the truncated proteins with the required sequence
present in the msn lamellocyte enhancer (data not shown),
suggesting an additional protein(s) may be needed to facilitate or
stabilize this protein-DNA interaction. As a second means to test
the ability of this dFos/dJun combination to interact with the
essential enhancer sequence, we were able to show the Drosophila
proteins could complex with a high-affinity AP-1 binding site
present in the hMTII promoter [21] (Fig. 6A and B). Formation of
this protein-DNA complex was inhibited by increasing amounts of
a wild-type DNA containing the msn enhancer AP-1 recognition
site, but not with a mutated version of this site (Fig. 6A and B). We
concluded the msn lamellocyte enhancer AP-1 sequence could
compete for dFos/dJun binding in this electromobility shift
competition assay, again implicating a role for the AP-1 complex
in the positive regulation of enhancer activity.
Mutation of the gene encoding Drosophila Fos strongly
suppresses lamellocyte production
As noted previously, the hop
Tum-l mutation results in a massive
overproduction of both lamellocytes and non-lamellocyte hemo-
cytes in larvae as compared to similarly-staged wild-type animals
(Fig. 7C). To investigate if mutations in the genes encoding dJun or
dFos proteins could lead to altered levels of lamellocyte differen-
tiation and/or hemocyte proliferation, we monitored blood cell
production in hop
Tum-l larvae that were also heterozygous mutant for
amorphic alleles of Jra and/or kay. While the introduction of the Jra
mutant allele showed a small affect on the level of lamellocyte
production and hemocyte proliferation as induced by hop
Tum-l,
introducing the kay mutant allele resulted in a robust 77%
suppression in the number of lamellocytes produced (Fig. 7A–C).
Introducing a Jra mutant allele to generate a hop
Tum-l/+; Jra
IA109/+;
kay
1/+ triple mutant condition led to an apparent further reduction
in lamellocyte production. However, statistical t-test analyses
Figure 6. The AP-1 recognition sequence in the msn lamellocyte enhancer can compete for dFos-dJun DNA binding. A. Sequence of
the hMTII AP-1 DNA probe, MSNF9 AP-1 recognition site, and mutated MSNF9 AP-1 recognition site. B. Electromobility shift competition assay with
hMTII wt AP-1, MSNF9 wt AP-1, and MSNF9 mut AP-1 double-stranded oligonucleotide DNAs.
doi:10.1371/journal.pone.0006429.g006
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double and triple mutant larvae. We concluded that reducing dFos
protein activity has a dramatic effect on lamellocyte production in
hop
Tum-l animals, also that decreasing dFos function enhances the
hyper-proliferative effect of the hop
Tum-l mutation. Such a finding is
consistent with a function of the AP-1 complex in the regulation of
the msn lamellocyte enhancer during the specification and
differentiation of this induced blood cell type.
Discussion
The msn
03349 enhancer trap allele has served as a valuable
marker for lamellocyte induction and differentiation [11,15,18].
This finding led us to a thorough search of msn upstream and
intragenic DNA for a transcriptional regulatory module with
activity in this inducible class of hemocytes. MSNF9 was shown to
contain DNA sequences that directed reporter gene expression
exclusively in lamellocytes, but not crystal cells or plasmatocytes of
hop
Tum-l larvae. Furthermore, this transcriptional enhancer was
functional in lamellocytes induced in several altered genetic
backgrounds, such as forced expression of the JNK pathway
components dRAC1 and hep
CA, the Wg pathway component
dTCF
DN, and the transcriptional regulators col and ush
DN.
Importantly, MSNF9-GFP-positive cells were induced in the lymph
glands and hemolymph of larvae infested by L. boulardi parasitoid
wasps, with numerous fluorescent lamellocytes contributing to the
encapsulation of injected eggs. Together these results demonstrat-
ed the identified msn enhancer had the properties of being
selectively activated in both genetically-compromised and im-
mune-challenged animals, wherein it served as a discriminating
sensor of lamellocyte production.
An interesting characteristic of the msn regulatory module is it
becomes functional in lamellocytes produced in the hemolymph
several hours prior to lamellocytes being detected in the lymph
glands of hop
Tum-l larvae. This earlier hemolymph appearance of
MSNF9-GFP-positive cells is consistent with lamellocytes being
derived from an extant population of hemocytes within the
hemolymph, such as the plasmatocyte sub-group of blood cells
[9,22]. This differential spatial and temporal appearance of
lamellocytes makes further sense in light of a recent study that
concluded during the onset of an immune response to wasp
parasitization, lamellocytes were derived from sessile hemocytes
Figure 7. Suppression of lamellocyte production by a mutant allele of kay, which encodes dFos. A. Supernumerary lamellocytes
produced in a hop
Tum-l/+ larva. B. Substantial reduction in the lamellocyte population in a hop
Tum-l/+; kay
1/+ larva. C. Quantification of the number of
lamellocytes and non-lamellocytes produced in larva of Canton S control versus mutant larvae. Asterisk (*) denotes a significant difference in values
from those observed in hop
Tum-l animals.
doi:10.1371/journal.pone.0006429.g007
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larva [12]. These investigations also demonstrated lymph gland-
derived lamellocytes appeared at a later stage of the immune
response, a time when they were likely to augment the
encapsulation of the introduced wasp egg.
Our in depth molecular analysis of the lamellocyte enhancer
allowed us to delimit the regulatory module to a 140-bp interval of
msn intron-3. This minimal DNA region was shown to possess an
essential DNA recognition element for the AP-1 transcription
factor complex. We also demonstrated a normal dosage of kay was
required for lamellocyte formation in hop
Tum-l larvae, since
introduction of one mutant allele of the gene encoding the dFos
subunit of AP-1 led to a strong suppression of lamellocyte
production. One interpretation of these findings is that the
lamellocyte enhancer present within msn intron-3 serves as a
transcriptional target within an activated JNK auto-regulatory
circuit that functions to continuously promote the differentiation of
lamellocytes from a progenitor hemocyte population (Fig. 8).
A final point of note is that this work has generated numerous
Drosophila strains that express either MSNF9-GFP or MSNF9-DsRed
selectively in lamellocytes, within the total population of
hemocytes present in immune-challenged or genetically-altered
larvae. Such transgenes can be used as sensitive probes to assess
the role of various genetic loci in the lamellocyte induction process.
Additionally, when used in conjunction with the growing
collection of UAS-RNAi lines designed to selectively inhibit the
functions of individual Drosophila genes, the MSNF9-Gal4 strain
may prove beneficial as a highly-specific GAL4 driver to newly-
discover molecules required for distinct aspects of lamellocyte
differentiation and function.
Materials and Methods
Drosophila strains
Canton S, w
1118, y
1 w
67c23, y
1 v
1 hop
Tum-l/Basc, HeGal4, CgGal4,
lzGal4; UAS-EGFP, UAS-dTCF
DN, UAS-dRac1, UAS-hep
CA, cn
1
Jra
IA109 bw
1 sp
1/CyO; TM6B, Sb Tb, and CyO, ActGFP were
obtained from the Bloomington Stock Center. kay
1/TM3, Sb
1 Ser
1
was provided by D. Bohmann and UAS-col was a gift from M.
Crozatier. Bc-GFP and eater-GFP have been previously described
[7,9]. To facilitate the counting of circulating hemocytes in single-
or double-heterozygous mutant larvae, kay
1 and Jra
IA109 were first
balanced over the TM6B, Sb Tb and CyO, ActGFP chromosomes,
respectively. All flies were maintained at room temperature or
25uC.
Generation of transgenic Drosophila strains for msn
enhancer analyses
To localize a msn DNA region with lamellocyte transcriptional
enhancer activity, we used PCR amplification of a msn-containing
BAC clone to generate nine genomic DNAs that spanned 22 kb of
upstream or intronic sequences. These DNAs were sub-cloned into
the P-element vectors pH-Stinger [23] and/or pRed H Pelican
[24]. Upon the identification of MSNF9-GFP as a DNA transgene
active in lamellocytes, but not other blood cell types, we used PCR
amplification to generate smaller truncated DNAs for enhancer
delimitation. Mutations of potential trans-regulator binding sites
were introduced in one of the truncated msn DNAs using the
QuickChange site-directed mutagenesis kit from Stratagene. After
sequence confirmation, altered msn DNAs were sub-cloned into
the pH Stinger vector. All msn enhancer test constructs were
injected into y
1 w
67c23 embryos, with multiple transgenic lines
generated using standard Drosophila transformation procedures
[25]. At least five lines were established and analyzed for each
DNA tested.
Hemocyte analyses by fluorescence imaging and cell
counting
To monitor and capture GFP and DsRed expression in live
animals, third instar larvae were anesthetized with ether,
moistened with a small amount of PBS, and viewed using a Zeiss
Stereo Lumar fluorescence stereomicroscope. To analyze circu-
lating hemocytes, larvae were bled into 10 ml PBS on a glass slide.
Hemolymph samples were allowed to settle for 30 min in a
humidity chamber, fixed for 5 min with 4% paraformaldehyde,
and incubated in 0.1% TritonX-PBS including Alexa Fluor 594-
conjugated phalloidin and DAPI. Images were obtained with a
Zeiss Axioplan 2 microscope or an Olympus Fluoview FV500
laser-scanning confocal microscope. To determine the concentra-
tion of circulating hemocytes and percent lamellocyte composition
therein, we used counting and statistical analyses described
previously [26]. For timed development of larvae, egg lays were
performed at 25uC for 1–4 hr, and hemolymph samples were
obtained and quantified thereafter at times indicated.
Electrophoretic mobility shift assays
Recombinant proteins containing 6XHis-tagged dJun or dFos
DNA-binding domains [27] were purified from E. coli by affinity
chromatography. Binding reactions were performed in a 20 ml
mixture containing 10 mM Tris-HCl (pH 8.0), 10 mM DTT,
2.5 mM MgCl2, 10% glycerol, 2 ml poly (dI-dC), 20 mg bovine
Figure 8. Model for the regulation of the msn gene during
lamellocyte induction and differentiation. The MSNF9 lamello-
cyte-active enhancer is depicted as serving as a transcriptional target
within a JNK pathway auto-regulatory circuit that promotes the
production of lamellocytes in immune-challenged or genetically
compromised animals. The schematic of the JNK pathway is adapted
from Xia and Karin (19).
doi:10.1371/journal.pone.0006429.g008
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1,000 cpm of
32P-labeled mMTII AP-1 DNA probe [21], with or
without wild type or mutant MSNF9 AP-1 oligonucleotide DNAs.
DNA fragments were purified and separated on polyacrylamide
gels.
Wasp infestation of Drosophila larvae
Batches of six early third-instar larvae were added to 4.5 ml of
fly food placed in a 35 mm Petri dish. Three Leptopilina boulardi (L.
boulardi strain Lb17) female wasps were added to each batch and
allowed to infect larvae for at least 2 hr. A batch of larvae to which
no wasps were added was used as a control. After 24 hr, non-
infested or infested larvae were removed from the fly food. Wasp
encapsulation nodules or lymph glands were dissected from larvae,
fixed in 4% paraformaldehyde in PBS, and stained with phalloidin
and DAPI. Images of GFP-expressing lamellocytes were obtained
with a Zeiss LSM510 confocal microscope.
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